Abstract:Numerous anti-inflammatory agents and corresponding therapeutic strategies have been explored for treating inflammation-related atherosclerosis, which has struggled with compromised antiatherosclerotic efficacy due to the complex pathogenesis. The senescent endothelial cells participate fundamentally at all stages in atherosclerosis, providing the basis for developing senotherapies to blunt the deleterious effects of senescent cells. In this work, a mesoporous palladium-boron-phosphorus ternary nanozyme with intrinsic superoxide dismutase/catalase-mimicking properties is rationally engineered to co-load H2 (an anti-inflammatory agent) within nanozyme's crystal lattice and 4,4 '-dimethoxychalcone (DIM, an anti-senescence agent) within mesopores, which elicits strong anti-inflammatory effect in pro-inflammatory macrophages by elimination of reactive oxygen species (ROS), H2 anti-inflammation and promotion of cholesterol efflux, while simultaneously exerts anti-senescence capacity in endothelial cells by protection of DNA from ROS damage and degradation of the cellular senescent components via autophagy activation. Both in vitro and in vivo experimental results verify the synergy between nanozyme-based anti-inflammatory therapy and autophagy activation, demonstrating that such a precise regulation of vascular senescence is applicable to augment antiatherosclerotic efficiency, which provides the nanomedicine-enabled and senotherapy-based paradigm for atherosclerosis management. A mesoporous palladium-boron-phosphorus ternary nanozyme with superoxide dismutase/catalase-mimicking abilities is developed to co-load H2 (an anti-inflammatory agent) within nanozyme's crystal lattice and 4,4 '-dimethoxychalcone (DIM, an anti-senescence agent) within mesopores, which elicits strong anti-inflammatory effect in pro-inflammatory macrophages, while simultaneously exerts anti-senescence capacity in endothelial cells, finally achieving desirable therapeutic effect for treatment of atherosclerosis. image

Combating Atherosclerosis with Chirality/Phase Dual‐Engineered Nanozyme Featuring Microenvironment‐Programmed Senolytic and Senomorphic Actions

Mesoporous Ternary Nanozymes with Anti‐Senescence and Anti‐Inflammation Activities for Atherosclerosis Management

Integrated Cascade Nanozymes with Antisenescence Activities for Atherosclerosis Therapy

Engineering Hierarchical Recognition-Mediated Senolytics for Reliable Regulation of Cellular Senescence and Anti-Atherosclerosis Therapy

Senolytic Therapy Enabled by Senescent Cell‐Sensitive Biomimetic Melanin Nano‐senolytics

Polyoxometalate-based nanozyme: Design of a multifunctional enzyme for multi-faceted treatment of Alzheimer’s disease

Activation‐Induced Senescent Cell Death based on Chiral CoHAu Nanoassemblies with Enantioselective Cascade‐Catalytic Ability

Living Macrophage-Delivered Tetrapod PdH Nanoenzyme for Targeted Atherosclerosis Management by ROS Scavenging, Hydrogen Anti-inflammation, and Autophagy Activation

Supramolecular Senolytics via Intracellular Oligomerization of Peptides in Response to Elevated Reactive Oxygen Species Levels in Aging Cells.

Ultra-small polydopamine nanomedicine-enabled antioxidation against senescence

Mitochondrial-mimicking nanozyme-catalyzed cascade reactions for aging attenuation

Tri-element Nanozyme PtCuSe As an Ingenious Cascade Catalytic Machine for the Amelioration of Parkinson’s Disease-Like Symptoms

Conversion of senescent cartilage into a pro-chondrogenic microenvironment with antibody-functionalized copper sulfate nanoparticles for efficient osteoarthritis therapy

Tri-element nanozyme PtCuSe as an ingenious cascade catalytic machine for the amelioration of Parkinson's disease-like symptoms

A Functionalized Octahedral Palladium Nanozyme as a Radical Scavenger for Ameliorating Alzheimer's Disease

Novel Metal-Free Nanozyme for Targeted Imaging and Inhibition of Atherosclerosis via Macrophage Autophagy Activation to Prevent Vulnerable Plaque Formation and Rupture

A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives

Chondroitin sulphate modified MoS2 nanoenzyme with multifunctional activities for treatment of Alzheimer's disease

Sustained Release of Hydrogen by PdH‐Te Nanozyme for Anti‐Inflammatory Therapy Against Atherosclerosis

Ultrathin 2D Pd/Cu Single-Atom MOF Nanozyme to Synergistically Overcome Chemoresistance for Multienzyme Catalytic Cancer Therapy

Defect engineering to tailor structure-activity relationship in biodegradable nanozymes for tumor therapy by dual-channel death strategies